Proteins in the sheath of cellular protrusions control how effectively cells can adhere to surfaces. Biological cells often ...

Chloe Yehwon Lee’s research could change the painkiller, known by the brand name Tylenol, for the better, ultimately reducing ...

Purdue University scientists have discovered a key mechanism that regulates how plants develop chloroplasts, essential ...

A groundbreaking study has introduced DNL-17, a newly synthesized aluminophosphate molecular sieve with a unique porous ...

Investing.com -- Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ: REGN) shares fell 1.5% following a U.S. appeals court decision that upheld a previous ruling, effectively denying a stay on ...

had infringed on U.S. Patent 11,084,865, claimed to cover a vial containing Eylea. As a result of the ruling, Amgen, which produces a biosimilar for Eylea, saw its shares increase by as much as 0.5%.

An appeals court has upheld a District Court’s denial of a preliminary injunction for Amgen’s (AMGN) Eylea biosimilar, which UBS analyst Trung Huynh tells investors in “negative, but ...

Regeneron Pharmaceuticals Inc. failed to convince the Federal Circuit to block an Amgen Inc. biosimilar of Eylea while the competitors duke it out in a patent lawsuit. Amgen’s biosimilar formulation ...

Researchers led by Prof. Dr. Hauke Hillen, head of the "Structure and Function of Molecular Machines" research group at the Department of Cellular Biochemistry at the University Medical Center ...

The fall of the Assad regime has created a historic opportunity to rid Syria of chemical weapons and ensure long-term compliance with the Chemical Weapons Convention (CWC), the UN’s top disarmament ...